CDCP1 and neoplasm: For CAFs, expression differences in genes like α-SMA, FAP, and CDCP1 enable identification of myCAFs (myofibroblast-like), iCAFs (inflammatory-like), and a novel CDCP1+FTL+ subtype; For TAMs, TANs, and neuro-associated cells (e.g., Schwann cells), transcription features were used for localization: CD68+CD163+ (M2-type TAMs), Ly6G+CXCL8+ (tumor-promoting TANs), and S100B+SOX10+ (Schwann cells) [50,51].